PRA is invested in bringing safe, effective, pediatric-tested treatments to children. We’ve contributed to the approval of 20 pediatric medicinal products.
Clinical research in pediatric populations faces different challenges and requires experienced development experts for study success. Our medical team is comprised of 25 board-certified pediatricians and physicians specializing in pediatric clinical development. Together, in collaboration with PRA’s Center for Pediatric Clinical Development, we provide innovative pediatric clinical development expertise to our sponsors that works for real families in the real world.
Pediatric experience over the past five years
Our global scientific network has extensive experience in pediatric clinical practice and pediatric clinical development. We bring our knowledge, expertise, and passion to deliver successful study strategy and study support at all stages of program development.Learn more about our partners in the Center for Pediatric Clinical Development
Children are not just small adults.
We leverage a data-driven approach and our many years of development experience to provide practical support for study design, feasibility, protocol development, and further pediatric study-related specificities. We have a deep knowledge of the global pediatric development landscape and diseases and provide operational training and support for all pediatric disease conditions.
Our team contains diverse therapeutic specialties and experience, retaining the most experience in clinical development in the following therapeutic areas:
- Oncology/Hematology/Cell Therapy
- Infectious Diseases
We keep the safety and best interest of our patients and their families at the center of all we do.
Decentralized Clinical Trials: Speaking the Same Language
The pandemic has accelerated adoption of clinical trial models that lessen the burden of participation on the patient and family care circle.…
Parents as Gatekeepers for Children with Cancer
The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular…
RACE Act is significantly changing clinical development. Are you ready?
Our team is here to help you navigate this historic transition in our industry.